In primary and established pancreatic cancer cells, MXRA5 depletion, using shRNA or CRISPR/Cas9 strategies, robustly suppressed cell viability, cell cycle progression, proliferation and motility, while provoking apoptosis. This evidence concerns the gene MXRA5 and familial pancreatic carcinoma.